Voyager Therapeutics (VOYJF.US) stock price is influenced by several factors: Clinical Trial Results: Positive data from clinical trials for Voyager's gene therapy programs typically drive the stock price up. Conversely, negative or inconclusive results can lead to a price decline. Regulatory Approval: Expectations and actual approval of Voyager's therapies by regulatory bodies like the FDA significantly impact investor sentiment and stock valuation. Partnerships & Collaborations: Agreements with larger pharmaceutical companies for development or commercialization of Voyager's products tend to boost investor confidence. Financial Performance: The company's cash runway, expenses, and ability to raise capital all influence the stock price, as Voyager is currently a development stage company. Market Conditions: General market sentiment, especially towards biotechnology and gene therapy stocks, can affect VOYJF.US, even without company-specific news. Competition: Progress and breakthroughs by competitor companies developing similar therapies can indirectly impact Voyager's perceived market potential. Intellectual Property: The strength and breadth of Voyager's patent portfolio play a role in determining the long-term value of the company.